Biosign Technologies (TSXV:BIO.H) Market Cap : C$0.11 Mil (As of May. 25, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biosign Technologies Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Biosign Technologies's share price for the quarter that ended in Sep. 2015 was C$0.11. Biosign Technologies's Shares Outstanding (EOP) for the quarter that ended in Sep. 2015 was 22.82 Mil. Therefore, Biosign Technologies's market cap for the quarter that ended in Sep. 2015 was C$2.51 Mil.

Biosign Technologies's quarterly market cap declined from Mar. 2015 (C$3.42 Mil) to Jun. 2015 (C$2.28 Mil) but then increased from Jun. 2015 (C$2.28 Mil) to Sep. 2015 (C$2.51 Mil).

Biosign Technologies's annual market cap increased from Dec. 2012 (C$4.22 Mil) to Dec. 2013 (C$9.69 Mil) but then declined from Dec. 2013 (C$9.69 Mil) to Dec. 2014 (C$2.28 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Biosign Technologies's Enterprise Value for Today is C$0.11 Mil.

Biosign Technologies Market Cap Historical Data

The historical data trend for Biosign Technologies's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosign Technologies Market Cap Chart

Biosign Technologies Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Market Cap

Get a 7-Day Free Trial

99.63

11.87

4.22

9.69

2.28

Biosign Technologies Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Market Cap	Get a 7-Day Free Trial															4.71	2.28	3.42	2.28	2.51

Competitive Comparison of Biosign Technologies's Market Cap

For the Health Information Services subindustry, Biosign Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosign Technologies's Market Cap Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Biosign Technologies's Market Cap distribution charts can be found below:

* The bar in red indicates where Biosign Technologies's Market Cap falls into.

Biosign Technologies Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Biosign Technologies's Market Cap for the fiscal year that ended in Dec. 2014 is calculated as

Market Cap (A: Dec. 2014 )	=	Share Price (A: Dec. 2014 )	*	Shares Outstanding (EOP) (A: Dec. 2014 )
	=	C$0.1	*	22.8232
	=	C$2.28

Biosign Technologies's Market Cap for the quarter that ended in Sep. 2015 is calculated as

Market Cap (Q: Sep. 2015 )	=	Share Price (Q: Sep. 2015 )	*	Shares Outstanding (EOP) (Q: Sep. 2015 )
	=	C$0.11	*	22.8232
	=	C$2.51

Biosign Technologies (TSXV:BIO.H) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Biosign Technologies Market Cap Related Terms

Thank you for viewing the detailed overview of Biosign Technologies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosign Technologies (TSXV:BIO.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Biosign Technologies Inc (TSXV:BIO.H) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

13-3715 Laird Road, Mississauga, ON, CAN, L5L 0A3

Website

http://www.biosign.com

Biosign Technologies Inc is a Canada based company engaged in the development and selling of cloud-based medical and healthcare software products. Its solutions have applications in clinic management, home care operations, health monitoring and virtual care management. The group derives its revenue from monthly recurring fees, one-time setup charges, training, professional services and the sale of hardware. The software is delivered through the cloud from the company's hosting facilities.

Biosign Technologies (TSXV:BIO.H) Headlines

No Headlines